YMAB
Y-mAbs Therapeutics
YMAB
YMAB
Delisted
YMAB was delisted on the 15th of September, 2025.
95 hedge funds and large institutions have $294M invested in Y-mAbs Therapeutics in 2024 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 35 increasing their positions, 34 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0% more funds holding
Funds holding: 95 → 95 (0)
21% less capital invested
Capital invested by funds: $374M → $294M (-$79.8M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
95
Holding in Top 10
–
Calls
$329K
Puts
$4K
Top Buyers
| 1 | +$19.8M | |
| 2 | +$17.5M | |
| 3 | +$1.73M | |
| 4 |
BlackRock
New York
|
+$984K |
| 5 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$930K |
Top Sellers
| 1 | -$14.1M | |
| 2 | -$3.37M | |
| 3 | -$2.74M | |
| 4 |
Los Angeles Capital Management
Los Angeles,
California
|
-$2.07M |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
-$1.88M |